hypericin has been researched along with Breast Cancer in 16 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "To investigate the effects of hypericin which is obtained from the plant Hypericum perforatum on the expression and the regulation of ADAMTS8 and ADAMTS9 genes in MCF7 breast cancer cells and on the viability of these cells." | 7.79 | Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells. ( Acar, M; Demircan, K; Gunduz, E; Gunduz, M; Ocak, Z; Ozlü, T; Uyeturk, U, 2013) |
| "Breast cancer is the most relevant type of cancer and the second cause of cancer- related deaths among women in general." | 5.56 | Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery. ( Caetano, W; César, GB; Consolaro, MEL; Damke, E; Damke, GMZF; Gonçalves, RS; Hioka, N; Kimura, E; Montanha, MC; Souza, RP, 2020) |
| "Hypericin (HY) is a naturally-occurring photosensitizer synthesized by plants of the genus Hypericum." | 5.51 | Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy. ( Fedoročko, P; Jendželovská, Z; Jendželovský, R; Kuchárová, B, 2019) |
| "Photoactivated hypericin increased production of reactive oxygen species in human breast adenocarcinoma MCF-7 as well as in MDA-MB-231 cells 1h after photodynamic therapy." | 3.85 | Photoactivated hypericin increases the expression of SOD-2 and makes MCF-7 cells resistant to photodynamic therapy. ( Fecková, B; Ilkovičová, L; Kello, M; Kimáková, P; Sačková, V; Solár, P; Solárová, Z, 2017) |
| "To investigate the effects of hypericin which is obtained from the plant Hypericum perforatum on the expression and the regulation of ADAMTS8 and ADAMTS9 genes in MCF7 breast cancer cells and on the viability of these cells." | 3.79 | Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells. ( Acar, M; Demircan, K; Gunduz, E; Gunduz, M; Ocak, Z; Ozlü, T; Uyeturk, U, 2013) |
| "The tumoricidal properties of photodynamic therapy (PDT) with hypericin (HY) were evaluated in a highly metastatic adenocarcinoma (DA3Hi) and anaplastic squamous cell carcinoma (SQ2) tumors in vivo." | 3.70 | Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors. ( Blank, M; Keisari, Y; Lavie, G; Mandel, M, 2000) |
| "Breast cancer is the most relevant type of cancer and the second cause of cancer- related deaths among women in general." | 1.56 | Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery. ( Caetano, W; César, GB; Consolaro, MEL; Damke, E; Damke, GMZF; Gonçalves, RS; Hioka, N; Kimura, E; Montanha, MC; Souza, RP, 2020) |
| "Hypericin (HY) is a naturally-occurring photosensitizer synthesized by plants of the genus Hypericum." | 1.51 | Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy. ( Fedoročko, P; Jendželovská, Z; Jendželovský, R; Kuchárová, B, 2019) |
| "Breast cancer is the major cause of death from cancer among women around the world." | 1.48 | Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231. ( Abbasi Gamasaee, N; Aryan, H; Ghiasvand, S; Jangholi, E; Javidi, MA; Radmansouri, M; Shahriari, F; Zare Marzouni, H, 2018) |
| "Bladder and breast cancer cells and their Pgp-overexpressing MDR subclones (MGHU1, MGHU1/R, MCF-7, MCF-7/R) were given hypericin/MTZ combinations, with/without blue-light illumination." | 1.34 | Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells. ( Adigbli, DK; Farooqui, N; Loizidou, M; Macrobert, AJ; Risley, P; Sousi, E; Taylor, I; Wilson, DG, 2007) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (6.25) | 18.2507 |
| 2000's | 3 (18.75) | 29.6817 |
| 2010's | 10 (62.50) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Zhou, X | 1 |
| Xu, X | 1 |
| Hu, Q | 1 |
| Wu, Y | 1 |
| Yu, F | 1 |
| He, C | 1 |
| Qian, Y | 1 |
| Han, Y | 1 |
| Tang, J | 1 |
| Hu, H | 1 |
| R Mokoena, D | 1 |
| P George, B | 1 |
| Abrahamse, H | 1 |
| You, MK | 1 |
| Kim, HJ | 1 |
| Kook, JH | 1 |
| Kim, HA | 1 |
| Abbasi Gamasaee, N | 1 |
| Radmansouri, M | 1 |
| Ghiasvand, S | 1 |
| Shahriari, F | 1 |
| Zare Marzouni, H | 1 |
| Aryan, H | 1 |
| Jangholi, E | 1 |
| Javidi, MA | 1 |
| Damke, GMZF | 1 |
| Souza, RP | 1 |
| Montanha, MC | 1 |
| Damke, E | 1 |
| Gonçalves, RS | 1 |
| César, GB | 1 |
| Kimura, E | 1 |
| Caetano, W | 1 |
| Hioka, N | 1 |
| Consolaro, MEL | 1 |
| Jendželovský, R | 1 |
| Jendželovská, Z | 1 |
| Kuchárová, B | 1 |
| Fedoročko, P | 3 |
| Ocak, Z | 1 |
| Acar, M | 1 |
| Gunduz, E | 1 |
| Gunduz, M | 1 |
| Demircan, K | 1 |
| Uyeturk, U | 1 |
| Ozlü, T | 1 |
| Kimáková, P | 1 |
| Solár, P | 3 |
| Fecková, B | 1 |
| Sačková, V | 1 |
| Solárová, Z | 2 |
| Ilkovičová, L | 1 |
| Kello, M | 1 |
| Theodossiou, TA | 1 |
| Olsen, CE | 1 |
| Jonsson, M | 1 |
| Kubin, A | 1 |
| Hothersall, JS | 1 |
| Berg, K | 1 |
| Ferenc, P | 2 |
| Kleban, J | 1 |
| Mikes, J | 2 |
| Koval', J | 1 |
| Hrčková, G | 1 |
| Fulton, BL | 1 |
| Song, S | 1 |
| Xiong, C | 1 |
| Zhou, M | 1 |
| Lu, W | 1 |
| Huang, Q | 1 |
| Ku, G | 1 |
| Zhao, J | 1 |
| Flores, LG | 1 |
| Ni, Y | 1 |
| Li, C | 1 |
| Blank, M | 2 |
| Lavie, G | 2 |
| Mandel, M | 2 |
| Hazan, S | 1 |
| Orenstein, A | 1 |
| Meruelo, D | 1 |
| Keisari, Y | 2 |
| Adigbli, DK | 1 |
| Wilson, DG | 1 |
| Farooqui, N | 1 |
| Sousi, E | 1 |
| Risley, P | 1 |
| Taylor, I | 1 |
| Macrobert, AJ | 1 |
| Loizidou, M | 1 |
| Miskovsky, P | 1 |
| Sureau, F | 1 |
| Chinsky, L | 1 |
| Turpin, PY | 1 |
1 review available for hypericin and Breast Cancer
| Article | Year |
|---|---|
Enhancing Breast Cancer Treatment Using a Combination of Cannabidiol and Gold Nanoparticles for Photodynamic Therapy.
Topics: Animals; Anthracenes; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cannabidiol; Combined Mod | 2019 |
15 other studies available for hypericin and Breast Cancer
| Article | Year |
|---|---|
Novel manganese and polyester dendrimer-based theranostic nanoparticles for MRI and breast cancer therapy.
Topics: Breast Neoplasms; Dendrimers; Female; Humans; Magnetic Resonance Imaging; Manganese; Nanoparticles; | 2023 |
St. John's Wort Regulates Proliferation and Apoptosis in MCF-7 Human Breast Cancer Cells by Inhibiting AMPK/mTOR and Activating the Mitochondrial Pathway.
Topics: AMP-Activated Protein Kinases; Anthracenes; Breast Neoplasms; Cell Line, Tumor; Humans; Hypericum; M | 2018 |
Hypericin Induces Apoptosis in MDA-MB-175-VII Cells in Lower Dose Compared to MDA-MB-231.
Topics: Anthracenes; Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Line, Tumor; Cell Proliferatio | 2018 |
Selective Photodynamic Effects on Breast Cancer Cells Provided by p123 Pluronic®- Based Nanoparticles Modulating Hypericin Delivery.
Topics: Anthracenes; Antineoplastic Agents; Breast Neoplasms; Cell Death; Cell Proliferation; Cell Survival; | 2020 |
Breast cancer resistance protein is the enemy of hypericin accumulation and toxicity of hypericin-mediated photodynamic therapy.
Topics: Anthracenes; Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily G, Member 2; Breast | 2019 |
Effect of hypericin on the ADAMTS-9 and ADAMTS-8 gene expression in MCF7 breast cancer cells.
Topics: ADAM Proteins; ADAMTS Proteins; ADAMTS9 Protein; Anthracenes; Breast Neoplasms; Cell Line, Tumor; Ce | 2013 |
Photoactivated hypericin increases the expression of SOD-2 and makes MCF-7 cells resistant to photodynamic therapy.
Topics: 2-Methoxyestradiol; Adenocarcinoma; Anthracenes; Breast Neoplasms; Cell Line, Tumor; Estradiol; Fema | 2017 |
The diverse roles of glutathione-associated cell resistance against hypericin photodynamic therapy.
Topics: Anthracenes; Breast Neoplasms; Buthionine Sulfoximine; Carmustine; Cell Line, Tumor; Drug Resistance | 2017 |
Down-regulation of Bcl-2 and Akt induced by combination of photoactivated hypericin and genistein in human breast cancer cells.
Topics: Anthracenes; bcl-2-Associated X Protein; Breast Neoplasms; Caspase 7; Cell Division; Cell Line, Tumo | 2010 |
Photoactivated hypericin induces downregulation of HER2 gene expression.
Topics: Anthracenes; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Female; Genes, erbB-2; Humans; Per | 2011 |
Small-animal PET of tumor damage induced by photothermal ablation with 64Cu-bis-DOTA-hypericin.
Topics: Ablation Techniques; Animals; Anthracenes; Biological Transport; Breast Neoplasms; Cell Line, Tumor; | 2011 |
Antimetastatic activity of the photodynamic agent hypericin in the dark.
Topics: Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous Cell; Disease Mod | 2004 |
Photochemical internalisation of chemotherapy potentiates killing of multidrug-resistant breast and bladder cancer cells.
Topics: Absorption; Anthracenes; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Deat | 2007 |
Subcellular distribution of hypericin in human cancer cells.
Topics: Anthracenes; Antiviral Agents; Breast Neoplasms; Fluorometry; Humans; Perylene; Protein Kinase C; Sp | 1995 |
Effects of photodynamic therapy with hypericin in mice bearing highly invasive solid tumors.
Topics: Adenocarcinoma; Animals; Anthracenes; Antineoplastic Agents; Breast Neoplasms; Carcinoma, Squamous C | 2000 |